Life support of artificial liver: Development of a bioartificial liver to treat liver failure

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 16, Issue 2, 2009, Pages 113-117

  Kobayashi, Naoya ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Bioartificial liver; Embryonic stem cells; Hepatocyte; Reversible immortalization

Indexed keywords

CRE RECOMBINASE; GANCICLOVIR; RETROVIRUS VECTOR; SCATTER FACTOR; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; BIOARTIFICIAL LIVER; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL IMMORTALIZATION; CELL ISOLATION; EMBRYONIC STEM CELL; ENZYME ACTIVITY; EPITHELIUM CELL; GENE TRANSFER; HUMAN; LIVER CELL; LIVER FAILURE; LIVER FUNCTION; LIVER REGENERATION; MESENCHYME CELL; NONHUMAN; SURVIVAL RATE; TISSUE ENGINEERING;

ANIMALS; CELL LINE; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; EQUIPMENT DESIGN; GRAFT REJECTION; GRAFT SURVIVAL; HEPATOCYTES; HUMANS; LIVER FAILURE; LIVER, ARTIFICIAL; TISSUE ENGINEERING;

EID: 63649106417     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00534-008-0022-1     Document Type: Article

References (22)

1. Langer R, Vacanti JP. Tissue engineering. Science. 1993;260:920-6.
2. Vacanti JP, Vacanti CA. The history and scope of tissue engineering. In: Lanza RP, Langer R, Vacanti J, editors. Principles of tissue engineering. San Diego: Academic Press; 2000. p. 3-7.
3. Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, et al. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science. 2000;287:1258-62.
4. Okitsu T, Kobayashi N, Jun HS, Shin S, Kim SJ, Han J, et al. Transplantation of reversibly immortalized insulin-secreting human hepatocytes controls diabetes in pancreatectomized pigs. Diabetes. 2004;53:105-12.
5. Totsugawa T, Yong C, Rivas-Carrillo JD, Soto-Gutierrez A, Navarro-Alvarez N, Noguchi H, et al. Survival of liver failure pigs by transplantation of reversibly immortalized human hepatocytes with tamoxifen-mediated self-recombination. J Hepatol. 2007;47:74-82.
6. Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Chen Y, Yamatsuji T, Tanaka N, et al. Differentiation of human embryonic stem cells to hepatocytes using deleted variant of HGF and poly-amino-urethane-coated nonwoven polytetrafluoroethylene fabric. Cell Transplant. 2006;15:335-41.
7. Chen Y, Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Yamatsuji T, Shirakawa Y, et al. Instant hepatic differentiation of human embryonic stem cells using activin A and a deleted variant of HGF. Cell Transplant. 2006;15:865-71.
8. Soto-Gutierrez A, Kobayashi N, Rivas-Carrillo JD, Navarro-Alvarez N, Zhao D, Okitsu T, et al. Reversal of mouse hepatic failure using an implanted liver-assist device containing ES cell-derived hepatocytes. Nat Biotechnol. 2006;24:1412-9.
9. Navarro-Alvarez N, Soto-Gutierrez A, Rivas-Carrillo JD, Fox IJ, Tanaka N, Kobayashi N. Stem cell-derived hepatocytes. Curr Opin Organ Transplant. 2006;11:659-664.
10. Watanabe T, Shibata N, Westerman KA, Okitsu T, Allain JE, Sakaguchi M, et al. Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers. Transplantation. 2003;75:1873-80.
11. Noguchi H, Kobayashi N, Westerman KA, Sakaguchi M, Okitsu T, Totsugawa T, et al. Controlled expansion of human endothelial cell populations by Cre/loxP-based reversible immortalization. Hum Gene Ther. 2002;13:321-34.
12. Maruyama M, Kobayashi N, Westerman KA, Sakaguchi M, Allain JE, Totsugawa T, et al. Establishment of a highly differentiated immortalized human cholangiocyte cell line with SV40T and hTERT. Transplantation. 2004;77:446-51.
13. Matsumura T, Takesue M, Westerman KA, Okitsu T, Sakaguchi M, Fukazawa T, et al. Establishment of an immortalized human-liver endothelial cell line with SV40T and hTERT. Transplantation. 2004;77:1357-65.
14. Sternberg N, Hamilton D. Bacteriophage P1 site-specific recombination. I. Recombination between loxP sites. J Mol Biol. 1981;150:467-86.
15. Narushima M, Kobayashi N, Okitsu T, Tanaka Y, Li SA, Chen Y. A human beta-cell line for transplantation therapy to control type 1 diabetes. Nat Biotechnol. 2005;23:1274-82.
16. Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, Marshall VS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145-7.
17. Rambhatla L, Chiu CP, Kundu P, Peng Y, Carpenter MK. Generation of hepatocyte-like cells from human embryonic stem cells. Cell Transplant. 2003;12:1-11.
18. Xu C, Inokuma MS, Denham J, Golds K, Kundu P, Gold JD, et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol. 2001;19:971-4.
19. Tanaka K, Kobayashi N, Soto-Gutierrez A, Rivas-Carrillo JD, Navarro-Alvarez N, Chen Y, et al. Prolonged survival of mice with acute liver failure with transplantation of monkey hepatocytes cultured with an antiapoptotic pentapeptide V5. Transplantation. 2006;81:427-37.
20. Ikeda H, Kobayashi N, Tanaka Y, Nakaji S, Yong C, Okitsu T, et al. A newly developed bioartificial pancreas successfully controls blood glucose in totally pancreatectomized diabetic pigs. Tissue Eng. 2006;12:1799-809.
21. Soto-Gutierrez A, Navarro-Alvarez N, Rivas-Carrillo JD, Tanaka K, Chen Y, Misawa H, et al. Construction and transplantation of an engineered hepatic tissue using a polyaminourethane-coated nonwoven polytetrafluoroethylene fabric. Transplantation. 2007;83:129-137.
22. Kobayashi N, Okitsu T, Nakaji S, Tanaka N. Hybrid bioartificial liver: establishing a reversibly immortalized human hepatocyte line and developing a bioartificial liver for practical use. J Artif Organs. 2003;6:236-44.